106 related articles for article (PubMed ID: 36163009)
1. The co-occurrence of both breast- and differentiated thyroid cancer: incidence, association and clinical implications for daily practice.
Piek MW; de Boer JP; van Duijnhoven F; van der Wal JE; Vriens M; van Leeuwaarde RS; van der Ploeg IMC
BMC Cancer; 2022 Sep; 22(1):1018. PubMed ID: 36163009
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal Co-existence of Female Thyroid and Breast Cancers in Hangzhou, China.
Fei X; Christakos G; Lou Z; Ren Y; Liu Q; Wu J
Sci Rep; 2016 Jun; 6():28524. PubMed ID: 27341638
[TBL] [Abstract][Full Text] [Related]
3. Association Between a History of Breast Cancer and Decreased Thyroid Cancer-specific Mortality.
Lin S; Wang Z; Xing M
J Clin Endocrinol Metab; 2024 Apr; 109(5):1222-1230. PubMed ID: 38064679
[TBL] [Abstract][Full Text] [Related]
4. Survival Outcomes in Thyroid Cancer Patients with Co-Occurring Breast Cancer: Evidence of Mortality Risk Attenuation.
Baumgarten MW; Goemann IM; Scheffel RS; Maia AL
Clin Breast Cancer; 2024 Apr; ():. PubMed ID: 38670860
[TBL] [Abstract][Full Text] [Related]
5. Risk of thyroid as a first or second primary cancer. A population-based study in Italy, 1998-2012.
Crocetti E; Mattioli V; Buzzoni C; Franceschi S; Serraino D; Vaccarella S; Ferretti S; Busco S; Fedeli U; Varvarà M; Falcini F; Zorzi M; Carrozzi G; Mazzucco W; Gasparotti C; Iacovacci S; Toffolutti F; Cavallo R; Stracci F; Russo AG; Caldarella A; Rosso S; Musolino A; Mangone L; Casella C; Fusco M; Tagliabue G; Piras D; Tumino R; Guarda L; Dinaro YM; Piffer S; Pinna P; Mazzoleni G; Fanetti AC; Dal Maso L;
Cancer Med; 2021 Oct; 10(19):6855-6867. PubMed ID: 34533289
[TBL] [Abstract][Full Text] [Related]
6. Time Intervals between Double Primary Breast and Ovarian Cancers and Survival Outcomes of Patients with Both Cancers: A SEER Database Analysis.
He XQ; Gao YT; Zhang X; Jiang H
Biomed Res Int; 2022; 2022():4557346. PubMed ID: 35707375
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of Patients With Second Primary Lung Cancer Following Breast Cancer: A Retrospective Descriptive Study.
Wang KY; Lee CS; Vempati P; Sharma R; Kohn N; Seetharamu N
Clin Lung Cancer; 2023 Sep; 24(6):e198-e204. PubMed ID: 37268494
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors of Synchronous Breast and Thyroid Cancer: a Controlled Multicenter Study and Review of the Literature.
Zervoudis S; Iatrakis G; Markja A; Tsatsaris G; Bothou A; von Tempelhoff GF; Balafouta M; Tsikouras P
Mater Sociomed; 2021 Dec; 33(4):298-303. PubMed ID: 35210954
[TBL] [Abstract][Full Text] [Related]
9. Risk and prognosis of second cutaneous melanoma after radiotherapy for breast cancer: A population-based analysis.
Luo T; Zhang Y; Chen T; Cai Y; Yang Z
Biomol Biomed; 2024 Jan; ():. PubMed ID: 38197802
[TBL] [Abstract][Full Text] [Related]
10. Changes in the incidence of early-onset breast cancer in Germany between 2010 and 2022.
Gremke N; Wagner U; Kalder M; Kostev K
Breast Cancer Res Treat; 2023 Nov; 202(1):167-172. PubMed ID: 37518826
[TBL] [Abstract][Full Text] [Related]
11. Double versus Single Primary Malignant Neoplasm of Breast and Colorectal Cancer: A Case-Control Study.
Tantiphlachiva K; Junprakhon P; Saetun S; Manasnayakorn S; Vongsaisuwan M; Vongwattanakit P; Vacharathit V
Asian Pac J Cancer Prev; 2024 Jan; 25(1):219-227. PubMed ID: 38285787
[TBL] [Abstract][Full Text] [Related]
12. Cancer Risk Factors in Southern Brazil: Report of a Comprehensive, Matched Case-Control Study.
Giacomazzi J; Ziegelmann PK; da Costa S; Bittar CM; Obst FM; Rosset C; Macedo GS; Bock H; Canal T; Paese MI; Benvenuti JL; Buj MC; Ashton-Prolla P; Goldim JR; Pozza R
JCO Glob Oncol; 2023 Sep; 9():e2300006. PubMed ID: 38060977
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of second primary breast cancer after ovarian cancer: a Korea central cancer registry retrospective study.
Lee EG; Lim J; Ha HI; Lim MC; Chang YJ; Won YJ; Jung SY
Front Oncol; 2023; 13():1208320. PubMed ID: 37781206
[TBL] [Abstract][Full Text] [Related]
14. Breast cancer incidence, stage distribution, and treatment shifts during the 2020 COVID-19 pandemic: a nationwide population-level study.
Peacock HM; van Walle L; Silversmit G; Neven P; Han SN; Van Damme N
Arch Public Health; 2024 May; 82(1):66. PubMed ID: 38715074
[TBL] [Abstract][Full Text] [Related]
15. The incidence of breast cancer in population of young women from Podkarpackie province in 2002-2011.
Radziszewska AU; Karczmarek-Borowska B; Grądalska-Lampart M; Filip AA
Contemp Oncol (Pozn); 2016; 20(2):176-84. PubMed ID: 27358599
[TBL] [Abstract][Full Text] [Related]
16. Synchronous Occurrence of Triple-Negative Breast Cancer and Malignant Melanoma.
Taushanova MS; Milusheva YI; Manov DA; Hadjieva RR; Yordanov AD
J Med Cases; 2023 Dec; 14(12):400-404. PubMed ID: 38186558
[TBL] [Abstract][Full Text] [Related]
17. Incidence of Breast Cancer and Enterococcus Infection: A Retrospective Analysis.
Cardeiro M; Ardeljan AD; Frankel L; Kim E; Takabe K; Rashid OM
World J Oncol; 2023 Feb; 14(1):32-39. PubMed ID: 36895996
[TBL] [Abstract][Full Text] [Related]
18. Association between breast cancer and thyroid cancer risk: a two-sample Mendelian randomization study.
Tan H; Wang S; Huang F; Tong Z
Front Endocrinol (Lausanne); 2023; 14():1138149. PubMed ID: 37288296
[TBL] [Abstract][Full Text] [Related]
19. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands.
Goldgar DE; Easton DF; Cannon-Albright LA; Skolnick MH
J Natl Cancer Inst; 1994 Nov; 86(21):1600-8. PubMed ID: 7932824
[TBL] [Abstract][Full Text] [Related]
20. Links between Breast and Thyroid Cancer: Hormones, Genetic Susceptibility and Medical Interventions.
Lu M; Liu H; Zheng B; Sun S; Chen C
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
